Member Info for Let-It-Roll

You do spout a load of b*ll*cks.

Because the MM's are trying to hoover up cheap shares, ready for the rise they know is coming :-) to sell much higher.

So they drop the price trying to get people to sell, who get jittery.

Only going to be good news imo.

More buying than selling so far on L2. Patience. The day is but young.

Quote: "The shorters rule this share until we go clinical nothing will change". is what you wrote, implying that the lacklustre share price is due to them. That is, and always has been rubbish.

You are talking rubbish here. Today has been a day of churn. +/- 5% is neither here or there. There have been many sellers today who are happy taking their up to 100% profit (depending on when they bought over the last months at the lows) . BUT as can be easily seen, those sells have been swallowed up by a number of buyers, either adding, or clearly in some cases loading up throughout the day.

The MM's have ran the share price up and down like a t*arts knickers today. Filling orders etc.

Later this week will be interesting. IMO

Irrespective of 'ramping' or not. The likelihood is that the share price may well be close to, equal or exceed 6p on commencement of clinical trials. Depending on what other news is released in the meantime. So are they really 'ramping'?

The amount of squabbling on this board is sometimes ridiculous. Just enjoy the moment.

Would be nice. But think 2.7-2.8 bid is more realistic. Volume will likely be 1/3rd of yesterday.

Trading & Poker

@AndrewPokerLife

·

8m

#HEMO Here are my thoughts: The 6p "value" of the strategic investment in the RNS has focused investors on the potential here. The 2.5p ceiling looked solid but it broke through. IMO continued rise over next days to 3.6p-4p pending Clinical Trial go ahead from FDA

and if 4p (ish) can be achieved, then a share price of 6p-7p is likely on the authorisation from the FDA to begin clinical trials. HEMO is still a steal at todays current close of 2.55p

A positive RNS this week on anything else, and they are toast.

Vlad needed that deal at 6p landed on Friday, as he has the Investor Presentation today. Now he can say.'Hey boyz. You want in, it's 6p+'

We also now have effectively a min valuation of Hemo now at 6p a share. :-)

Subscription at 6p. And strategic Paetnership. Today is going to be a good day!

I'm every the optimist. One possible explanation for the rushed RNS after trading today, is that there is already a planned RNS for 7am Monday with the CART-T Clinical Hold Release, and Hemo didn't want it to look like the rise this afternoon was due to a leak of that information. As that would of course prompt "insider" allegations. So they released after hours the explanation re the patent to confirm the reason for the SP rise.

Regardless, it is still good news! The Pharma world will now be able to see CBR for what it can really do. That can only be a good thing for Hemo and the SP.

Lets's hope for a 4+ on Monday morning :-)

8th on the LSE Share Riser Board now..

And up we go...

07.09.2023 Application Body as Filed If you read through this PDF, it really is quite exciting as to what CBR can do. Referencing "Foot and Mouth", "SARS Covid" and lots of other viruses. Worth a wade through.

If it's RNS'd on Monday morning 7am.. then that will garner attention :-)

However, the publication date is down as yesterday: 07/09/23.

1. WO2023168292 - CHIMERIC BAIT RECEPTORS AND USES THEREOF

PCT Biblio. Data

Description

Claims

Drawings

Sequence Listing

National Phase

Notices

Documents

Submit observation

PermaLink

Notifications of changes after publication

Publication Date Publication Kind Publication Reason

07.09.2023 A2 Initial Publication without ISR

If you look at the lows on the 3 month chart, then we are climbing, painfully slowly, but it is climbing. As Mr I said, as soon as there is a hint of news, the SP will move fast (very).